HEMOPHILIA A OR B

Clinical trials for HEMOPHILIA A OR B explained in plain language.

Never miss a new study

Get alerted when new HEMOPHILIA A OR B trials appear

Sign up with your email to follow new studies for HEMOPHILIA A OR B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Pfizer monitors new hemophilia drug for safety

Disease control Ongoing

This study is checking the safety of a drug called Hympavzi in real-world use by patients with hemophilia A or B. It will follow about 50 patients for up to three years to see if any unexpected side effects occur. The main goal is to understand the drug's safety profile after it …

Matched conditions: HEMOPHILIA A OR B

Sponsor: Pfizer • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

HEMOPHILIA A OR B

Get alerted when new HEMOPHILIA A OR B trials appear

Pfizer monitors new hemophilia drug for safety